The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also showed promise in
previously treated pancreatic cancer patients with the mutation, according to results from a phase II clinical study.
Immune - based strategies to
treat pancreatic cancer during the early stages of development, as well as new immunological approaches to treat advanced disease, are showing significant promise where other approaches have failed.
«We are now working to optimise this class of compounds, but it's clearly worthy of further investigation for potential use
in treating pancreatic cancer in people,» he said.
A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously -
treated pancreatic cancer.
Professor Andrew Biankin, a Cancer Research UK pancreatic cancer expert at the University of Glasgow, said: «PRECISION Panc aims to transform how
we treat pancreatic cancer by matching the right treatment to the right patient.
Genetic manipulation of exosomes, virus - sized particles released by all cells, may offer a new therapeutic approach to
treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center.
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in
treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
The findings support a precision approach to
treating pancreatic cancer, the fourth most deadly cancer for both men and women.
Another common and newer drug used to
treat pancreatic cancer is gemcitabine, which also mimics one of the building blocks of DNA and interferes with the ability of cancer cells to reproduce.
Their findings reveal urgently needed new targets to
treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.
Despite all of this bad news, researchers are aggressively looking for new avenues to
treat pancreatic cancer.
The findings suggest that therapies combining these microRNAs and gemcitabine could improve our ability to
treat pancreatic cancer, and measurement of microRNA levels could also provide a guide to the prognosis in such cases.
A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to
treat pancreatic cancer, reveals research published online in the Journal of Clinical Pathology.
The only way to
treat pancreatic cancer is to remove it before it spreads.
The successful results are a critical step toward a precision medicine approach to detecting and
treating pancreatic cancer, which has one of the lowest survival rates of all cancers.
The first request for applications (RFA) will seek projects focusing on pre-clinical development research to increase the number of innovative and effective therapies to
treat pancreatic cancer.
Unless cancer immunologists can find a way to penetrate this armor surrounding the tumor, then immunotherapies such as adoptive T cell therapy are likely to be ineffective at
treating pancreatic cancer.
University of Chicago radiation oncologists were among the first in the nation to use intensity modulated radiation therapy (IMRT) to
treat pancreatic cancer.
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in
treating pancreatic cancer, according to an early study by Queen Mary University of London.
This project will continue the work to understand what makes a high - quality neoantigen and how the microbiome influences how the immune system recognizes it, with the goal of developing a method for creating vaccines to
treat pancreatic cancers.
Requests for applications (RFA's) will be issued on April 30 to support pre-clinical development research seeking to increase the number of innovative and effective therapies to
treat pancreatic cancer.
External radiation therapy is used to
treat pancreatic cancer.
The first thing you notice about Diane Simeone, M.D., the Lazar J. Greenfield Professor of Surgery and director of the Pancreatic Cancer Research Center, is her tireless passion for finding better ways to detect and
treat pancreatic cancer.
Erlotinib is a type of TKI used to
treat pancreatic cancer.
For example, curcumin, which is an extract from the tumeric plant, has been used in the past to augment chemotherapy medications in
treating pancreatic cancer,» he says, adding that many plants contain antioxidant properties that fight cancer by boosting -LSB-...]